S-Adenosylmethionine for osteoarthritis of the knee or hip

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Rutjes, Anne W S ^a   Nüesch, Eveline ^a   Reichenbach, Stephan ^a   Jüni, Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; S ADENOSYLMETHIONINE;

CLINICAL TRIAL; DRUG EFFECT; DRUG SAFETY; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; PAIN; REVIEW; SYSTEMATIC REVIEW;

EID: 55049089336     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007321     Document Type: Review

References (16)

1. Altman 1996 Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, et al.Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996;4(4):217-43.
2. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
3. di Padova 1987 di Padova C. S-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studies. The American Journal of Medicine 1987;83(5A):60-5.
4. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286- 91.
5. Fetrow 2001 Fetrow CW, Avila JR. Efficacy of the dietary supplement S-adenosyl-L-methionine. The Annals of Pharmacotherapy 2001;35(11):1414-25.
6. Hardy 2002 Hardy M, Coulter I, Morton SC, et al.S-Adenosyl-L- Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease. Evidence Report/Technology Assessment Number 64. (Prepared by Southern California Evidence-based Practice Center under Contract No. 290-97-0001). AHRQ Publication No. 02-E034 Rockville, MD: Agency for Healthcare Research and Quality. 2002, issue October: URL: http://www.ahrq.gov/clinic/tp/sametp. htm#Report (assessed at 8 May 2008).
7. Harmand 1987 Harmand MF, Vilamitjana J, Maloche E, Duphil R, Ducassou D. Effects of S-adenosylmethionine on human articular chondrocyte differentiation. An in vitro study. The American Journal of Medicine 1987;83(5A):48-54.
8. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
9. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
10. Juni 2006 Juni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Practice and Research. Clinical Rheumatology 2006;20(4):721-40.
11. Pham 2004 Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, HochbergM, et al.OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12(5):389-99.
12. Reichenbach 2007 Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, et al.Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Annals of Internal Medicine 2007;146(8):580-90.
13. Soeken 2002 Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BM. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. The Journal of Family Practice 2002;51(5):425-30.
14. Sterne 2001 Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046-55.
15. Thompson 1999 Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Statistics in Medicine 1999;18(20):2693-708.
16. Witte 2002 Witte S, Lasek R, Victor N. Meta-analysis of the efficacy of adenosyl-methionine and oxaceprol in the treatment of osteoarthritis [Wirksamkeit von Ademetionin und Oxaceprol fur die Behandlung von Arthrosen Eine Metaanalyse]. Orthopade 2002;31(11):1058-65.